Grossman, Henderson honored by international blood association
Recognized for research on convalescent plasma, COVID-19
![](https://medicine.wustl.edu/wp-content/uploads/Grossman-250x345.jpeg)
The Association for the Advancement of Blood & Biotherapies recently honored Brenda J. Grossman, MD, and Jeffrey P. Henderson, MD, PhD, noted researchers at Washington University School of Medicine in St. Louis, with a 2021 President’s Award.
Grossman, a professor of pathology & immunology and of medicine, and Henderson, an associate professor of medicine and of molecular microbiology, were recognized for their work as part of the COVID-19 Convalescent Plasma Project Group, which helped to advance the science regarding therapeutic options for convalescent plasma.
![](https://medicine.wustl.edu/wp-content/uploads/Henderson-250x345.jpeg)
Convalescent plasma involves transfusing antibodies from the blood of patients who have recovered from an infectious disease — in this case, COVID-19 — into patients who are ill with the virus, to help treat the infection. Grossman and Henderson have contributed to several studies about convalescent plasma and COVID-19. One study found that convalescent plasma from recovered COVID-19 patients can dramatically improve the likelihood of survival among blood cancer patients hospitalized with the virus.
The Association for the Advancement of Blood & Biotherapies is a nonprofit organization dedicated to advancing the field. For more information on the award, please see here.